% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • daviscupper daviscupper Aug 29, 2012 11:39 AM Flag

    Adam Feuerstein is a cautious analyst but...

    Takiing into account that 19 out of 20 startup biotechs eventually fail it is prudent, and some might say wise, to not be overly optimistic on any new biotech company. Having said that we already have past comments by Adam regarding Celsion.

    For him his initial assessments were quite optimistic. Basically he said that he saw nothing wrong with the technology, trials, management. In fact he was cautiously optimistic about our breakthrough technology. The only caveat he added was, and this was back in last November, he wasn't sure investors would be enthusiastic about buying anytime soon because meaningful results would not be forthcoming until the fourth quarter. Otherwise he was causiously pretty upbeat.

    Now, time has passed on. The fourth quarter is right around the corner. Feuerstein will also note, in my opinion, that we have begun to acquire the attention of many international KOLs and significant and well-respected international partners. And he recently has noted that Wall Street has overlooked this stock, which gives us the potential to see another spike in the pps.

    I think his new appraisal of Celsion and ThermoDox will be very positive and declare the upside potential is stratospheric. However, Feuerstein being Feuerstein, he will also say that it is a speculative buy and everything depends on clinical results.

    The bottom line is his assessment will be a net positive and hundreds of thousands of new potential investors will be taking a fresh look at Celsion and ThermoDox. Many of those new potential investors will dip their toes in and I suspect we will get a new mega-spike in the pps. Cheers.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.09+0.01(+0.93%)Feb 12 3:59 PMEST